Rational engineering of a functional CpG-free ITR for AAV gene therapy

Overview of attention for article published in Gene Therapy, October 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 4,937 followers.

RT @GeneTherapy_SN: Online now, CpG-free inverted terminal repeats in #AAVs for #Duchennemusculardystrophy #genetherapy have comparable mic…

RT @GeneTherapy_SN: Online now, CpG-free inverted terminal repeats in #AAVs for #Duchennemusculardystrophy #genetherapy have comparable mic…

Online now, CpG-free inverted terminal repeats in #AAVs for #Duchennemusculardystrophy #genetherapy have comparable micro-dystrophin transgene expression as wildtype AAVs. #GTArticle here➡️https://t.co/EcjoTvkrNX 📸: Dystrophin (red) in CpG-free AAV treated

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.